Novaccess Global Stock Cash And Equivalents
| XSNX Stock | USD 0.0001 0.00 0.00% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess NovAccess Global's long-term financial health and intrinsic value.
NovAccess |
NovAccess Global Company Cash And Equivalents Analysis
NovAccess Global's Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Current NovAccess Global Cash And Equivalents | 89.94 K |
Most of NovAccess Global's fundamental indicators, such as Cash And Equivalents, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NovAccess Global is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
| Competition |
In accordance with the recently published financial statements, NovAccess Global has 89.94 K in Cash And Equivalents. This is 99.99% lower than that of the Healthcare sector and 99.98% lower than that of the Biotechnology industry. The cash and equivalents for all United States stocks is 100.0% higher than that of the company.
NovAccess Cash And Equivalents Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NovAccess Global's direct or indirect competition against its Cash And Equivalents to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NovAccess Global could also be used in its relative valuation, which is a method of valuing NovAccess Global by comparing valuation metrics of similar companies.NovAccess Global is currently under evaluation in cash and equivalents category among its peers.
NovAccess Fundamentals
| Return On Asset | -5.13 | |||
| Current Valuation | 5.75 M | |||
| Shares Outstanding | 19.57 M | |||
| Shares Owned By Insiders | 53.19 % | |||
| Shares Owned By Institutions | 7.74 % | |||
| Price To Earning | 2.69 X | |||
| Price To Sales | 2.87 X | |||
| Gross Profit | 752.56 K | |||
| EBITDA | (21.5 K) | |||
| Net Income | (1.72 M) | |||
| Cash And Equivalents | 89.94 K | |||
| Total Debt | 165.88 K | |||
| Current Ratio | 0.04 X | |||
| Book Value Per Share | (0.50) X | |||
| Cash Flow From Operations | (903.49 K) | |||
| Earnings Per Share | (0.24) X | |||
| Beta | 1.55 | |||
| Market Capitalization | 4.11 M | |||
| Total Asset | 124.9 K | |||
| Retained Earnings | (42.63 M) | |||
| Working Capital | (726 K) | |||
| Current Asset | 65 K | |||
| Current Liabilities | 791 K | |||
| Net Asset | 124.9 K |
About NovAccess Global Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NovAccess Global's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NovAccess Global using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NovAccess Global based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.